Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $180.92 USD
Change Today -0.67 / -0.37%
Volume 166.9K
PRGO On Other Exchanges
Symbol
Exchange
New York
Tel Aviv
Frankfurt
As of 11:16 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

perrigo co plc (PRGO) Key Developments

Perrigo Mulls Acquisitions

Perrigo Company Public Limited Company (NYSE:PRGO) is looking for acquisitions. Joe Papa, Chief Executive Officer of Perrigo said that the company generally looks at acquisitions in the $100 million to $1 billion range. The official admitted that Perrigo could look at even larger deals. Joe Papa added that in addition to deals to bolster the range of products Perrigo offers to U.S. drugstores and grocers, the company could also seek deals in adult nutrition, diabetes or wound care.

Perrigo Company plc Announces Quarterly Dividend Payable on September 15, 2015

Perrigo Company plc announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on September 15, 2015 to shareholders of record on August 28, 2015.

Perrigo Company Public Limited Company Announces Consolidated Unaudited Earnings Results for the Second Quarter Ended June 27, 2015; Records Goodwill Impairment Charge for the Second Quarter of 2015; Provides Earnings Guidance for the Third Quarter and Full Year 2015

Perrigo Company Public Limited Company announced consolidated unaudited earnings results for the second quarter ended June 27, 2015. For the quarter, the company reported net sales of $1,531.6 million compared with $1,144.2 million for the same period a year ago. Operating income was $226.9 million compared with $197.4 million for the same period a year ago. Income before income taxes was $157.4 million compared with $165.5 million for the same period a year ago. Net income was $56.4 million or $0.38 per diluted share compared with $131.7 million or $0.98 per diluted share for the same period a year ago. Adjusted operating income was $436.9 million compared with $324.6 million for the same period a year ago. Adjusted income before tax was $385.9 million compared with $296.2 million for the same period a year ago. Adjusted net income was $320.3 million or $2.18 per diluted share compared with $234.1 million or $1.74 per diluted share for the same period a year ago. For the quarter, the company recorded goodwill impairment charge of $6.8 million. The company anticipates both the third and fourth calendar quarter tax rates to increase to approximately 18.5% due to the inclusion of estimated earnings before tax from Omega Pharma. This jump in the rate is a function of the accounting rules surrounding annualizing effective tax rate. The company expects third calendar quarter 2015 adjusted net income to grow between 30% and 35% over the comparable 2014 period. The company continues to expect calendar year 2015 adjusted earnings per diluted share range of $7.50 to $8.00, an increase of 20% to 28% over calendar 2014 adjusted earnings per share. While the adjusted annual effective tax rate is still expected to be approximately 17% for the full calendar year 2015.

Perrigo Company Public Limited Company to Report Q2, 2015 Results on Aug 05, 2015

Perrigo Company Public Limited Company announced that they will report Q2, 2015 results at 8:00 AM, US Eastern Standard Time on Aug 05, 2015

Perrigo Company Public Limited Company, Q2 2015 Earnings Call, Aug 05, 2015

Perrigo Company Public Limited Company, Q2 2015 Earnings Call, Aug 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRGO:US $180.92 USD -0.67

PRGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $76.32 USD +1.36
Hospira Inc $89.95 USD 0.00
Mead Johnson Nutrition Co $77.47 USD +0.75
Mylan NV $48.87 USD +0.25
Sun Pharmaceutical Industries Ltd 884.95 INR -5.20
View Industry Companies
 

Industry Analysis

PRGO

Industry Average

Valuation PRGO Industry Range
Price/Earnings 100.0x
Price/Sales 5.7x
Price/Book 2.5x
Price/Cash Flow 205.1x
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERRIGO CO PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.